Announcements Trials

Browse Landscape

Status

Unknown 2 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Melanoma 1

Interventions

Cisplatin 18 pembrolizumab 12 Paclitaxel 9 Carboplatin 9 Radiotherapy 5 Gemcitabine 4 Fluorodeoxyglucose F18 4 Colposcopy 4 Brachytherapy 4 fludarabine 3 durvalumab 3 Surveys and Questionnaires 3 Radiation 3 Flow Cytometry 3 Cyclophosphamide 3 Biopsy 3 Bevacizumab 3 toripalimab 2 fludarabine phosphate 2 atezolizumab 2 aldesleukin 2 adavosertib 2 Zoledronic Acid 2 Topotecan 2 Nivolumab 2 Neoadjuvant Therapy 2 Microarray Analysis 2 Magnetic Resonance Spectroscopy 2 Interviews as Topic 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Uterine Cervical Neoplasms × Lymph Node Excision × Clear all

NCT06752135 2024-12-30

HRCC1

Azienda Policlinico Umberto I

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡